Post Market Clinical Follow-up (PMCF)Study of the Contour Neurovascular SystemTM

NCT04579081 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-03-22

No results posted yet for this study

Summary

Cerus Endovascular is sponsoring a prospective, multi-center PMCF to document the safety and performance of the Contour Neurovascular System™ (hereinafter "Contour") in normal medical use.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

Contour Neurovascular System

Intrasaccular flow disruptor/divertor

Sponsors & Collaborators

  • Cerus Endovascular, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2022-06-30
Completion
2023-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579081 on ClinicalTrials.gov